12 results on '"Guha, Chandana"'
Search Results
2. School attendance and sport participation amongst children with chronic kidney disease: a cross-sectional analysis from the Kids with CKD (KCAD) study
- Author
-
Hudson, Adam C., van Zwieten, Anita, Mallitt, Kylie-Ann, Durkan, Anne, Hahn, Deirdre, Guha, Chandana, Khalid, Rabia, Didsbury, Madeleine, Francis, Anna, McTaggart, Steven, Mackie, Fiona E., Prestidge, Chanel, Teixeira-Pinto, Armando, Lah, Suncica, Howell, Martin, Howard, Kirsten, Nassar, Natasha, Jaure, Allison, Craig, Jonathan C., Wong, Germaine, and Kim, Siah
- Published
- 2024
- Full Text
- View/download PDF
3. Baseline characteristics of participants in the NAVKIDS2 trial: a patient navigator program in children with chronic kidney disease
- Author
-
Guha, Chandana, Khalid, Rabia, van Zwieten, Anita, Francis, Anna, Hawley, Carmel M., Jauré, Allison, Teixeira-Pinto, Armando, Mallard, Alistair R., Bernier-Jean, Amelie, Johnson, David W., Hahn, Deirdre, Reidlinger, Donna, Pascoe, Elaine M., Ryan, Elizabeth G., Mackie, Fiona, McCarthy, Hugh J., Craig, Jonathan C., Varghese, Julie, Kiriwandeniya, Charani, Howard, Kirsten, Larkins, Nicholas G., Macauley, Luke, Walker, Amanda, Howell, Martin, Irving, Michelle, Caldwell, Patrina H. Y., Woodleigh, Reginald, Jesudason, Shilpanjali, Carter, Simon A., Kennedy, Sean E., Alexander, Stephen I., McTaggart, Steven, and Wong, Germaine
- Published
- 2023
- Full Text
- View/download PDF
4. Consumer Involvement in Research and Decision-Making in Nephrology
- Author
-
Scholes-Robertson, Nicole, Gutman, Talia, Guha, Chandana, Levin, Adeera, Gallego, Daniel, Malheiros, Kelly, Tong, Allison, Bezerra da Silva Junior, Geraldo, editor, and Nangaku, Masaomi, editor
- Published
- 2022
- Full Text
- View/download PDF
5. NAVKIDS2 trial: a multi-centre, waitlisted randomised controlled trial of a patient navigator intervention in children with chronic kidney disease — statistical analysis plan and update to the protocol
- Author
-
van Zwieten, Anita, Ryan, Elizabeth G., Caldwell, Patrina, Howard, Kirsten, Tong, Allison, Craig, Jonathan C., Alexander, Stephen I., Howell, Martin, Teixeira-Pinto, Armando, Hawley, Carmel M., Jesudason, Shilpanjali, Walker, Amanda, Mackie, Fiona, Kennedy, Sean E., McTaggart, Steven, McCarthy, Hugh J., Carter, Simon A., Kim, Siah, Woodleigh, Reginald, Francis, Anna, Mallard, Alistair R., Bernier-Jean, Amélie, Johnson, David W., Hahn, Deirdre, Reidlinger, Donna, Pascoe, Elaine, Varghese, Julie, Kiriwandeniya, Charani, Vergara, Liza, Larkins, Nicholas, Macauley, Luke, Irving, Michelle, Khalid, Rabia, Guha, Chandana, and Wong, Germaine
- Published
- 2022
- Full Text
- View/download PDF
6. NAV-KIDS2 trial: protocol for a multi-centre, staggered randomised controlled trial of a patient navigator intervention in children with chronic kidney disease
- Author
-
van Zwieten, Anita, Caldwell, Patrina, Howard, Kirsten, Tong, Allison, Craig, Jonathan C., Alexander, Stephen, Howell, Martin, Armando, Teixeira-Pinto, Hawley, Carmel, Jesudason, Shilpa, Walker, Amanda, Mackie, Fiona, Kennedy, Sean, McTaggart, Steve, McCarthy, Hugh, Carter, Simon, Kim, Siah, Crafter, Sam, Woodleigh, Reginald, Guha, Chandana, and Wong, Germaine
- Published
- 2019
- Full Text
- View/download PDF
7. Partnering with patients and caregivers to enrich research and care in kidney disease: values and strategies.
- Author
-
Cazzolli, Rosanna, Sluiter, Amanda, Guha, Chandana, Huuskes, Brooke, Wong, Germaine, Craig, Jonathan C, Jaure, Allison, and Scholes-Robertson, Nicole
- Subjects
CHRONICALLY ill ,KIDNEY diseases ,PATIENT participation ,CAREGIVERS ,BUSINESS partnerships ,CHRONIC kidney failure - Abstract
Patient and caregiver involvement broadens the scope of new knowledge generated from research and can enhance the relevance, quality and impact of research on clinical practice and health outcomes. Incorporating the perspectives of people with lived experience of chronic kidney disease (CKD) affords new insights into the design of interventions, study methodology, data analysis and implementation and has value for patients, healthcare professionals and researchers alike. However, patient involvement in CKD research has been limited and data on which to inform best practice is scarce. A number of frameworks have been developed for involving patients and caregivers in research in CKD and in health research more broadly. These frameworks provide an overall conceptual structure to guide the planning and implementation of research partnerships and describe values that are essential and strategies considered best practice when working with diverse stakeholder groups. This article aims to provide a summary of the strategies most widely used to support multistakeholder partnerships, the different ways patients and caregivers can be involved in research and the methods used to amalgamate diverse and at times conflicting points of view. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Baseline characteristics of participants in the NAVKIDS2 trial: a patient navigator program in children with chronic kidney disease.
- Author
-
Guha, Chandana, Khalid, Rabia, van Zwieten, Anita, Francis, Anna, Hawley, Carmel M., Jauré, Allison, Teixeira-Pinto, Armando, Mallard, Alistair R., Bernier-Jean, Amelie, Johnson, David W., Hahn, Deirdre, Reidlinger, Donna, Pascoe, Elaine M., Ryan, Elizabeth G., Mackie, Fiona, McCarthy, Hugh J., Craig, Jonathan C., Varghese, Julie, Kiriwandeniya, Charani, and Howard, Kirsten
- Subjects
- *
CHRONIC kidney failure , *RESEARCH , *HEALTH services accessibility , *SOCIAL determinants of health , *PATIENT-centered care , *RANDOMIZED controlled trials , *SOCIOECONOMIC factors , *RESEARCH funding , *DESCRIPTIVE statistics , *QUALITY of life , *STATISTICAL sampling - Abstract
Background: Children with chronic kidney disease (CKD) require multidisciplinary care to meet their complex healthcare needs. Patient navigators are trained non-medical personnel who assist patients and caregivers to overcome barriers to accessing health services through care coordination. This trial aims to determine the effectiveness of a patient navigator program in children with CKD. Methods: The NAVKIDS2 trial is a multi-center, waitlisted, randomized controlled trial of patient navigators in children with CKD conducted at five sites across Australia. Children (0–16 years) with CKD from low socioeconomic status rural or remote areas were randomized to an intervention group or a waitlisted control group (to receive intervention after 6 months). The study primary and secondary endpoints include the self-rated health (SRH) (primary), and utility-based quality of life, progression of kidney dysfunction of the child, SRH, and satisfaction with healthcare of the caregiver at 6 months post-randomization. Results: The trial completed recruitment in October 2021 with expected completion of follow-up by October 2022. There were 162 patients enrolled with 80 and 82 patients randomized to the immediate intervention and waitlisted groups, respectively. Fifty-eight (36%) participants were from regional/remote areas, with a median (IQR) age of 9.5 (5.0, 13.0) years, 46% were of European Australian ethnicity, and 65% were male. A total of 109 children (67%) had CKD stages 1–5, 42 (26%) were transplant recipients, and 11 (7%) were receiving dialysis. Conclusion: The NAVKIDS2 trial is designed to evaluate the effectiveness of patient navigation in children with CKD from families experiencing socioeconomic disadvantage. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Patient and caregiver perspectives on blood pressure in children with chronic kidney disease.
- Author
-
Wu, Justin Guang-Ao, Tong, Allison, Evangelidis, Nicole, Manera, Karine E, Hanson, Camilla S, Baumgart, Amanda, Amir, Noa, Sinha, Aditi, Dart, Allison, Eddy, Allison A, Guha, Chandana, Gipson, Debbie S, Bockenhauer, Detlef, Yap, Hui-Kim, Groothoff, Jaap, Zappitelli, Michael, Alexander, Stephen I, Furth, Susan L, Samuel, Susan, and Carter, Simon A
- Subjects
BLOOD pressure ,PEDIATRIC nephrology ,CHRONIC kidney failure ,PATIENTS' attitudes ,PATIENT-centered care ,CARDIOVASCULAR diseases ,KIDNEY failure - Abstract
Background More than 50% of children with chronic kidney disease (CKD) have uncontrolled hypertension, increasing their long-term risk of cardiovascular disease and progression to kidney failure. Children receiving medications or dialysis may also experience acute blood pressure fluctuations accompanied by debilitating symptoms. We aimed to describe the perspectives of children with CKD and their parental caregivers on blood pressure to inform patient-centered care. Methods Secondary thematic analysis was conducted on qualitative data from the Standardized Outcomes in Nephrology—Children and Adolescents initiative, encompassing 16 focus groups, an international Delphi survey and two consensus workshops. We analyzed responses from children with CKD (ages 8–21 years) and caregivers (of children ages 0–21 years) pertaining to blood pressure. Results Overall, 120 patients and 250 caregivers from 22 countries participated. We identified five themes: invisibility and normalization (reassured by apparent normotension, absence of symptoms and expected links with CKD), confused by ambiguity (hypertension indistinguishable from cardiovascular disease, questioning the need for prophylactic intervention, frustrated by inconsistent messages and struggling with technical skills in measurement), enabling monitoring and maintaining health (gaging well-being and preventing vascular complications), debilitating and constraining daily living (provoking anxiety and agitation, helpless and powerless and limiting life activities) and burden of medications (overwhelmed by the quantity of tablets and distress from unexpected side effects). Conclusions For children with CKD and their caregivers, blood pressure was an important heath indicator, but uncertainty around its implications and treatment hampered management. Providing educational resources to track blood pressure and minimizing symptoms and treatment burden may improve outcomes in children with CKD. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Qualitative research methods and its application in nephrology.
- Author
-
Guha, Chandana, Viecelli, Andrea K., Wong, Germaine, Manera, Karine, and Tong, Allison
- Subjects
- *
QUALITATIVE research , *PATIENTS' attitudes , *CHRONIC kidney failure , *NEPHROLOGY , *QUALITY of life - Abstract
Chronic kidney disease is associated with an increased risk of mortality, comorbidities and life‐threatening complications. Invasive treatments including dialysis or transplantation, complex pharmacological therapies, dietary restrictions and the ongoing need to attend follow‐up appointments can place a substantial treatment burden on patients and carers and impair quality of life. This highlights the need for care that is responsive to the needs of patients and involves them in decision‐making to achieve the most appropriate healthcare outcomes. Shared decision‐making and collaborative approaches to care require a deep awareness of the lived experiences and goals of patients. Qualitative research methods can provide insights into patients' experiences, values and priorities and inform practice and policy by uncovering their preferences for care. Qualitative methods are increasingly being used in standalone projects or in mixed methods studies (complementing quantitative studies) to make valuable contributions to patient‐centred research. Patient‐centred care, collaborations between patient and care provider, and shared decision‐making that integrates with the patient's goals are central to quality healthcare. The efficacy of qualitative research lies in its ability to elicit patients' perspectives, values, priorities and goals that underpin shared decision making and care. This article discusses examples of how qualitative research has informed practice and policy in nephrology, provides a summary of qualitative research methods and outlines a guide on how to appraise, interpret and apply qualitative data. SUMMARY AT A GLANCE: This invited review article discusses examples of how qualitative research has informed practice and policy in nephrology, provides a summary of qualitative research methods and outlines a guide on how to appraise, interpret and apply qualitative data in research. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Standardised Outcomes in Nephrology - Chronic Kidney Disease (SONG-CKD): a protocol for establishing a core outcome set for adults with chronic kidney disease who do not require kidney replacement therapy.
- Author
-
Evangelidis, Nicole, Sautenet, Benedicte, Madero, Magdalena, Tong, Allison, Ashuntantang, Gloria, Sanabria, Laura Cortes, de Boer, Ian H., Fung, Samuel, Gallego, Daniel, Levey, Andrew S., Levin, Adeera, Lorca, Eduardo, Okpechi, Ikechi G., Rossignol, Patrick, Sola, Laura, Usherwood, Tim, Wheeler, David C., Cho, Yeoungjee, Howell, Martin, and Guha, Chandana
- Abstract
Background: Globally, over 1.2 million people die from chronic kidney disease (CKD) every year. Patients with CKD are up to 10 times more likely to die prematurely than progress to kidney failure requiring kidney replacement therapy. The burden of symptoms and impaired quality of life in CKD may be compounded by comorbidities and treatment side effects. However, patient-important outcomes remain inconsistently and infrequently reported in trials in patients with CKD, which can limit evidence-informed decision-making. The Standardised Outcomes in Nephrology - Chronic Kidney Disease (SONG-CKD) aims to establish a consensus-based core outcome set for trials in patients with CKD not yet requiring kidney replacement therapy to ensure outcomes of relevance to patients, caregivers and health professionals are consistently reported in trials.Methods: SONG-CKD involves four phases: a systematic review to identify outcomes (domains and measures) that have been reported in randomised controlled trials involving adults with CKD who do not require kidney replacement therapy; stakeholder key informant interviews with health professionals involved in the care of adults with CKD to ascertain their views on establishing core outcomes in CKD; an international two-round online Delphi survey with patients, caregivers, clinicians, researchers, policy makers and industry representatives to obtain consensus on critically important outcome domains; and stakeholder consensus workshops to review and finalise the set of core outcome domains for trials in CKD.Discussion: Establishing a core outcome set to be reported in trials in patients with CKD will enhance the relevance, transparency and impact of research to improve the lives of people with CKD.Trial Registration: Not applicable. This study is registered with the Core Outcome Measures in Effectiveness Trials (COMET) database: http://www.comet-initiative.org/Studies/Details/1653 . [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
12. NAV-KIDS2 trial: protocol for a multi-centre, staggered randomised controlled trial of a patient navigator intervention in children with chronic kidney disease.
- Author
-
van Zwieten, Anita, Caldwell, Patrina, Howard, Kirsten, Tong, Allison, Craig, Jonathan C., Alexander, Stephen, Howell, Martin, Armando, Teixeira-Pinto, Hawley, Carmel, Jesudason, Shilpa, Walker, Amanda, Mackie, Fiona, Kennedy, Sean, McTaggart, Steve, McCarthy, Hugh, Carter, Simon, Kim, Siah, Crafter, Sam, Woodleigh, Reginald, and Guha, Chandana
- Subjects
PEDIATRIC nephrology ,ORGAN transplant waiting lists ,MEDICAL personnel ,HEALTH services accessibility ,CLINICAL trial registries ,EXPLORERS ,CHILD care ,TREATMENT of chronic kidney failure ,MEDICAL care standards ,RESEARCH ,MEDICAL care ,PATIENTS ,PATIENT-centered care ,MEDICAL cooperation ,RANDOMIZED controlled trials ,ALLIED health personnel - Abstract
Background: Chronic kidney disease (CKD) is a devastating illness associated with increased mortality, reduced quality of life, impaired growth, neurocognitive impairment and psychosocial maladjustment in children. There is growing evidence of socioeconomic disparities in health outcomes among children with CKD. Patient navigators are trained non-medical personnel who assist patients with chronic conditions journey through the continuum of care and transit across different care settings. They help vulnerable and underserved populations to better understand their diagnosis, treatment options, and available resources, guide them through complex medical systems, and help them to overcome barriers to health care access. Given the complexity and chronicity of the disease process and concerns that current models of care may not adequately support the provision of high-level care in children with CKD from socioeconomically disadvantaged backgrounds, a patient navigator program may improve the provision of care and overall health of children with CKD.Methods: The NAV-KIDS2 trial is a multi-centre, staggered entry, waitlisted randomised controlled trial assessing the health benefits and costs of a patient navigator program in children with CKD (stages 3-5, on dialysis, and with kidney transplants), who are of low socioeconomic backgrounds. Across 5 sites, 210 patients aged from 3 to 17 years will be randomised to immediate receipt of a patient navigator intervention for 24 weeks or waitlisting with standard care until receipt of a patient navigator at 24 weeks. The primary outcome is child self-rated health (SRH) 6-months after completion of the intervention. Other outcomes include utility-based quality of life, caregiver SRH, satisfaction with healthcare, progression of kidney dysfunction, other biomarkers, missed school days, hospitalisations and mortality. The trial also includes an economic evaluation and process evaluation, which will assess the cost-effectiveness, fidelity and barriers and enablers of implementing a patient navigator program in this setting.Discussion: This study will provide clear evidence on the effectiveness and cost-effectiveness of a new intervention aiming to improve overall health and well-being for children with CKD from socioeconomically disadvantaged backgrounds, through a high quality, well-powered clinical trial.Trial Registration: Prospectively registered (12/07/2018) on the Australian New Zealand Clinical Trials Registry ( ACTRN12618001152213 ). [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.